Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis-Reference-Cited by-同舟云学术

Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis

Published:2016-09 Issue: Volume:85 Page:45-50
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Meier Elisabeth M.,Pohl Rebekka,Rein-Fischboeck Lisa,Schacherer Doris,Eisinger Kristina,Wiest Reiner,Krautbauer Sabrina,Buechler Christa^ORCID

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference41 articles.

1. Molecular mediators of hepatic steatosis and liver injury;Browning;J. Clin. Invest.,2004

2. Adiponectin, a key adipokine in obesity related liver diseases;Buechler;World J. Gastroenterol.,2011

3. Obesity, adipokines and hepatocellular carcinoma;Duan;Int. J. Cancer,2013

4. Adiponectin: key player in the adipose tissue-liver crosstalk;Moschen;Curr. Med. Chem.,2012

5. Systemic fate of the adipocyte-derived factor adiponectin;Halberg;Diabetes,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal and Urinary Adipokines as Disease Biomarkers;Biomedicines;2023-04-16

2. The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery;Lipids in Health and Disease;2022-01-16

3. Chronic mineral oil administration increases hepatic inflammation in wild type mice compared to lipocalin 2 null mice;Laboratory Investigation;2021-09-13

4. Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent;Toxicology;2021-09

5. Lipocalin 2 as a potential systemic biomarker for central serous chorioretinopathy;Scientific Reports;2020-11-19